Universal Corporation (UVV) - Q2 2026 10-Q Summary
Business Context and Reporting Period
Universal Corporation is a global business-to-business agri-products supplier, primarily known as the leading global leaf tobacco supplier and a provider of plant-based ingredients for food and beverage markets. This report covers the quarterly period ended September 30, 2025 (Fiscal Q2 2026) and the six months ended September 30, 2025. The company operates through two segments: Tobacco Operations and Ingredients Operations.
Key Financial Metrics
| Metric (in millions, except per share) | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Revenue | $754.2 | $710.8 | $1,347.9 | $1,307.8 |
| Operating Income | $67.6 | $68.7 | $101.5 | $86.0 |
| Net Income (Attributable to Universal) | $34.2 | $25.9 | $42.7 | $26.1 |
| Diluted EPS | $1.36 | $1.03 | $1.70 | $1.04 |
| Operating Cash Flow | — | — | ($172.4) Used | ($47.4) Used |
| Free Cash Flow | — | — | ($192.6) Used | ($84.8) Used |
| Total Debt | $1,157.8 | $1,196.8 | $1,157.8 | $1,196.8 |
| Cash & Equivalents | $88.7 | $80.1 | $88.7 | $80.1 |
| Net Debt (Non-GAAP) | $1,071.9 | $1,123.5 | $1,071.9 | $1,123.5 |
Note: Operating cash flow is negative for the six-month period due to seasonal working capital investments in tobacco inventory.
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenue increased 6% in Q2 and 3% YTD, driven by higher tobacco and ingredient sales volumes. Tobacco Operations revenue rose 5% in Q2, while Ingredients Operations revenue surged 18%.
- Profitability: Operating income decreased 2% in Q2 but increased 18% YTD. The Q2 decline was due to higher inventory write-downs ($7.5M), unfavorable foreign currency impacts ($5.1M), and higher provisions for farmer advances ($2.0M).
- Restructuring Costs: Restructuring and impairment costs dropped significantly to $0 in Q2 2025 and $1.1M YTD, compared to $10.6M in the prior year periods. These prior costs were related to the consolidation of European sheet tobacco operations.
- Segment Performance: Tobacco Operations operating income fell 16% in Q2 due to currency and inventory issues but rose 10% YTD. Ingredients Operations operating income declined 112% in Q2 and 64% YTD due to product mix, higher fixed costs from facility expansion, and inventory write-downs.
- Working Capital: Tobacco inventory increased by $332.3M YTD to $1.14B due to seasonal crop purchases. Uncommitted inventory remains low at 13% of total tobacco inventory.
Guidance, Outlook, and Risks
- Outlook: Management expects capital expenditures of $45M to $55M over the next twelve months. The company anticipates continued firm demand for tobacco despite larger crops, with green tobacco prices softening in some regions. Ingredients demand remains solid, though the segment faces headwinds from consumer-packaged goods weakness and tariff uncertainty.
- Capital Allocation: The company maintains a $100M share repurchase program (authorized Nov 2024, expires Nov 2026) with the full amount remaining available as of September 30, 2025. No shares were repurchased in Q2.
- Dividends: Dividends declared were $0.82 per share in Q2 and $1.64 YTD.
- Material Weakness in Internal Controls: The company disclosed a material weakness in internal control over financial reporting related to inventory counting and reconciliation at a tobacco subsidiary. Management concluded disclosure controls were not effective as of September 30, 2025, though no restatement was required. A remediation plan is underway.
- Risks: Key risks include reliance on a few large customers, tobacco growing conditions, foreign currency fluctuations, and regulatory changes regarding tobacco products. The company also faces potential impacts from the "One Big Beautiful Bill Act" (OBBBA), though management does not currently anticipate a material impact.
Investor Verification Checklist
- Inventory Valuation: Verify the adequacy of inventory write-downs ($9.8M YTD) and the valuation of uncommitted tobacco inventory ($144.2M) given the material weakness in inventory controls.
- Foreign Currency Exposure: Assess the impact of currency fluctuations on future margins, as Q2 results were negatively impacted by $5.1M in unfavorable currency comparisons.
- Ingredients Segment Margins: Monitor the Ingredients segment's ability to offset higher fixed costs and depreciation from recent facility expansions with volume growth.
- Internal Control Remediation: Track the progress of the remediation plan for the inventory control material weakness to ensure future financial reporting reliability.
- Working Capital Cycle: Confirm that the significant cash outflow for operating activities ($172.4M YTD) aligns with seasonal expectations and will reverse in the second half of the fiscal year.